|
| |
 |
| SIMOVIL 80 MG |
סימוביל 80 מ"ג |
|
|
|
|
| כן, יש ללחוץ כאן לפירוט |
בסל הבריאות?: |
|
|
| Coronary Heart Disease : In patients with coronary heart disease and hypercholesterolemia Simovil is indicated to: Reduce the risk of total mortality by reducing coronary death Reduce the risk of non-fatal myocardial infarction Reduce the risk for undergoin myocardial revascularization procedures. Reduce the risk of stroke and transient ischemic attacks (TIA). Hyperlipidemia: Simovil is indicated as an adjunct to diet to reduce elevated TOTAL-C LDL-C Apo B and TG and to increase HDL-C in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (Frederickson Types IIa and IIb) Simovil therefore lowers the LDL-C/HDL-C and the total-C/HDL-C ratios. Homozygous familial hypercholesterolemia: Simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol LDL-cholesterol and apolipoprotein B in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. Hypertriglyceridemia (fredrickson type IV hyperlipidemia): Simovil is indicated for the treatment of patients with hypertriglyceridemia (Fredrickson type IV hyperlipidemia). Dysbetalipoproteinemia ( Fredrickson type III hyperlipidemia). Simovil is indicated for the treatment of patients with primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia). |
התוויה מאושרת: |
|
| TABLETS |
דרך מתן:
|
|
| MERCK SHARP & DOHME ISRAEL LTD |
בעל רישום: |
|
| 114-78-29681-00 |
מספר רישום:
|
|
|
| רכיב פעיל |
כמות |
|
| SIMVASTATIN |
80 MG |
|
| ATC description |
|
|
|
| ATC-ניתן ללחוץ על קבוצת ה |
|
|
|
| מחיר לצרכן כולל מע"מ |
כמות |
תאור אריזה |
קוד ירפא |
|
| 126.69 |
30 |
SIMOVIL 80 MG 30 TAB |
20535
|
|
|
|
 |
INFO ON THE WEB |
מידע ברשת |
|
|
|
|
|
|
